David T. Davies

Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae

Martin Everett, Nicolas Sprynski, Alicia Coelho et al. · Antimicrobial Agents and Chemotherapy · 2018 · 94 citations · Full text

Biarylcarbamoylindolines Are Novel and Selective 5-HT_2C Receptor Inverse Agonists:  Identification of 5-Methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a Potential Antidepressant/Anxiolytic Agent

Steven M. Bromidge, Steven Dabbs, David T. Davies et al. · Journal of Medicinal Chemistry · 2000 · 79 citations · Full text

Potential Antidepressant/anxiolytic Agent, Psychotropic Medication, Inverse Agonists +18

Design, synthesis and structure–activity relationships of substituted oxazole–benzamide antibacterial inhibitors of FtsZ

Neil R. Stokes, Nicola Baker, James M. Bennett et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 78 citations

Antimicrobial Drug Discovery, Biochemistry, Medicine +7

Novel and Selective 5-HT_2C/2B Receptor Antagonists as Potential Anxiolytic Agents:  Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines

Steven M. Bromidge, Steven Dabbs, David T. Davies et al. · Journal of Medicinal Chemistry · 1998 · 64 citations · Full text

Biological Activity, Molecular Pharmacology, Medicinal Chemistry +15

Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases

Timothy J. Miles, Alan J. Hennessy, B.D. Bax et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 63 citations · Full text

Inhibitory Activity, Medicinal Chemistry, Medicine +13